Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 12, 2016
Purdue Pharma L.P. and Exicure, Inc. have announced a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis, and other diseases amenable to a gene regulation approach utilizing Exicure’s ...
read more
Puma and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and commercialize NERLYNX® (neratinib) within Europe and part of Africa.
read more
Wednesday, March 20, 2019
Pulse Biosciences announced the appointment of Mitchell Levinson to its board of directors.
read more
Thursday, October 07, 2021
Pulmodyne, Inc., a leading provider of drug atomization delivery, and Alcove Manufacturing and Distribution, Inc., announced the partnership between the two companies to expand distribution, integrate manufacturing, and to continue joint development ...
read more
Pulmatrix and Cipla announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole™, an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole.
read more
Wednesday, September 06, 2017
Pulmatrix has partnered with Vectura Group to develop Pulmatrix's drug candidate, PUR0200, for COPD for the U.S. market.
read more
Pulmatrix has entered into a research collaboration with Nocion Therapeutics to explore new technologies to enable and improve inhaled drug delivery.
read more
Pulmatrix has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson.
read more
A collaboration with Aldevron, LLC to secure GMP manufacturing capacity for PTC's gene therapy portfolio
read more
Wednesday, April 06, 2016
PGI Drug Discovery has announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. has achieved a milestone.
read more
PsyBio Therapeutics has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit.
read more
PSI CRO, a global full-service contract research organization, is opening a new office in Durham, North Carolina, in the region known as Research Triangle Park (RTP).
read more
Thursday, January 15, 2026
PSI CRO announced further expansion in Japan, with the opening of the second office located on Level 18 of the Hilton Plaza West Office Tower in Umeda, Kita-ku, Osaka.
read more
Friday, September 22, 2017
PSI CRO has announced opening offices in Taiwan, listed as Taiwan PSI Health Development at TAIPEI 101 TOWER, Taipei, Taiwan.
read more
Wednesday, January 07, 2026
PSI CRO, a Swiss-based contract research organization, has expanded its Toronto operations with the opening of a new office location in Ontario. The expansion builds on PSI’s long-standing presence in the Canadian clinical trial market, where the ...
read more